LeMaitre to Present at May 13 Healthcare Conference, Wins Zacks #2 Buy
LMAT•LeMaitre Vascular will present at the Bank of America Healthcare Conference on May 13 at 5:15 PM PT. The stock earned a Zacks Rank #2 upgrade and highlights above-average financial growth in revenue and earnings, signaling improved earnings prospects for growth investors.
1. Conference Presentation Scheduled
LeMaitre management is set to deliver a presentation at the Bank of America Healthcare Conference on Wednesday, May 13, 2026, at 5:15 PM PT. The session will cover the company’s recent operational performance, strategic initiatives in peripheral vascular disease treatment, and outlook for device and service revenues.
2. Zacks Upgrades to Rank #2 (Buy)
Analysts have upgraded LeMaitre to a Zacks Rank #2 (Buy), reflecting upward revisions in earnings estimates and growing optimism about future profitability. The upgrade underscores positive analyst sentiment following the company’s latest financial disclosures.
3. Above-Average Growth Drivers
LeMaitre reported above-average revenue and earnings growth in its latest quarter, driven by expansion of its implantable and disposable vascular device lines. The company addresses a global market of over 200 million peripheral vascular disease patients, with service offerings providing recurring revenue streams.
